Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
53,203,068
-
Share change
-
-779,241
-
Total reported value
-
$258,565,571
-
Price per share
-
$4.86
-
Number of holders
-
101
-
Value change
-
-$14,356,748
-
Number of buys
-
46
-
Number of sells
-
42
Institutional Holders of GENMARK DIAGNOSTICS INC - COM (GNMK) as of Q4 2018
As of 31 Dec 2018,
GENMARK DIAGNOSTICS INC - COM (GNMK) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,203,068 shares.
The largest 10 holders included
FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, CADIAN CAPITAL MANAGEMENT, LP, Casdin Capital, LLC, JPMORGAN CHASE & CO, BlackRock Inc., Vanguard Group Inc, HighTower Advisors, LLC, Bellevue Group AG, and BANK OF AMERICA CORP /DE/.
This page lists
101
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.